Interní Med. 2012; 14(12): 458-460

Diuretics and beta blockers in treating hypertension

prof.MUDr.Jiří Vítovec, CSc., FESC1, prof.MUDr.Jindřich ©pinar, CSc.2
1 I. interní kardioangiologická klinika LF MU FN u sv. Anny, Brno
2 Interní kardiologická klinika LF MU a FN Brno

In treating high blood pressure, both diuretics and beta blockers are among the primary drugs for blood pressure control; however, due

to their metabolic adverse effects, they are not among the first-choice drugs in uncomplicated hypertension. Diuretics are administered

in edema, cardiac failure, isolated systolic hypertension, and in elderly patients. Beta blockers are used in all forms of ischemic heart

disease, including post-myocardial infarction conditions, in cardiac failure, and in increased sympathetic tone with hyperkinetic circulation.

Clear indications, inappropriate indications, and contraindications for these antihypertensive drugs are explained. The article

highlights inappropriate use of both hydrochlorothiazide and atenolol alone in the treatment of uncomplicated hypertension, which

does not apply to fixed combinations of diuretics with ACE inhibitors or sartans.

Keywords: diuretics, beta blockers, hypertension

Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, ©pinar J. Diuretics and beta blockers in treating hypertension. Interní Med. 2012;14(12):458-460.
Download citation

References

  1. Widimský J, a kol. Arteriální hypertenze 3. vydání Triton 2008; s. 450.
  2. Widimsky J jr., Cifkova R, ©pinar J, a spol. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Cor Vasa 2008; 50: K5-22.
  3. Heller J. Mechanizmus účinku diuretik. Remedia 1994; 4: 248-253.
  4. Al Badarin FJ, et al. Evidence-Based Diuretic Therapy for Improving Cardiovascular Prognosis in Systemic Hypertension. Am J Cardiol 2011; 107: 1178-1184. Go to original source... Go to PubMed...
  5. Messerli FH, Bangalor S. Half a Century of Hydrochlorothiazide: Facts, Fads, Fiction, and Follies. Am J Med 2011; 124: 896-899. Go to original source... Go to PubMed...
  6. Dorsch MP, Gillespie BW, Erickson RS, et al. Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide A Retrospective Cohort Analysis. Hypertension. 2011; 57: 689-694. Go to original source... Go to PubMed...
  7. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009; 361: 2153-2164. Go to original source... Go to PubMed...
  8. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004; 364: 1684-1689. Go to original source... Go to PubMed...
  9. Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G. Efficacy and tolerability profile of nebivolol vs atenolol in mild-tomoderate essential hypertension: results of a double-blind randomized multicentre trial. Blood Press 2003; 12(suppl 2): 35-40. Go to original source...
  10. Sica DA. Beta-Blockers in Hypertension. J Clin Hypertens. 2007; 9(4 suppl 3): 4-9. Go to original source... Go to PubMed...
  11. Vítovec J, ©pinar. Farmakoterapie kardiovaskulárních onemocnění. 2. vydání, Grada Praha 2004: s. 252.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.